Farallon Capital Management 13F holdings, Q2 2019
Holdings as of June 30, 2019 · filings on SEC EDGAR · latest filing →
Farallon Capital Management disclosed 103 US equity positions worth $14.3bn in its Q2 2019 13F filing. The largest position was ALTABA INC at 13.8% of the reported book, followed by CELG and RED HAT INC. Against the Q1 2019 filing, it opened 4 new positions, added to 24 and reduced 19 among the top 50 holdings.
What did Farallon Capital Management own in Q2 2019? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2019 |
|---|---|---|---|---|---|---|---|
| 1 | ALTABA INC | 13.8% | $2.0bn | 28,362,317 | 3% | added | |
| 2 | CELG CELGENE CORP | 10.0% | $1.4bn | 15,445,000 | 83% | added | |
| 3 | RED HAT INC | 6.7% | $963.7m | 5,132,800 | 54% | added | |
| 4 | ANADARKO PETE CORP | 5.2% | $738.4m | 10,465,000 | – | new | |
| 5 | WELLCARE HEALTH PLANS INC | 4.4% | $634.3m | 2,225,000 | 297% | added | |
| 6 | WAB WABTEC CORP | Industrials | 3.3% | $471.3m | 6,568,373 | 5% | added |
| 7 | IQV IQVIA HLDGS INC | Healthcare | 2.9% | $415.0m | 2,579,011 | 20% | added |
| 8 | ARRAY BIOPHARMA INC | 2.8% | $393.8m | 8,500,000 | 55% | added | |
| 9 | FIS FIDELITY NATL INFORMATION SV | Technology | 2.4% | $348.7m | 2,842,640 | 34% | added |
| 10 | ELV ANTHEM INC | Healthcare | 2.1% | $296.3m | 1,050,000 | 27% | added |
| 11 | CHTR CHARTER COMMUNICATIONS INC N | Communication Services | 1.9% | $276.8m | 700,405 | -13% | reduced |
| 12 | GD GENERAL DYNAMICS CORP | Industrials | 1.7% | $242.8m | 1,335,214 | 23% | added |
| 13 | PLAYA HOTELS & RESORTS NV | 1.6% | $236.0m | 30,606,930 | 0% | held | |
| 14 | IHS MARKIT LTD | 1.6% | $229.7m | 3,604,997 | -41% | reduced | |
| 15 | SHW SHERWIN WILLIAMS CO | Basic Materials | 1.5% | $213.4m | 465,699 | 21% | added |
| 16 | V VISA INC | Financial Services | 1.4% | $206.1m | 1,187,779 | -26% | reduced |
| 17 | EFX EQUIFAX INC | Industrials | 1.4% | $198.0m | 1,463,779 | -25% | reduced |
| 18 | EQIX EQUINIX INC | Real Estate | 1.4% | $193.2m | 383,132 | -8% | reduced |
| 19 | SPGI S&P GLOBAL INC | Financial Services | 1.3% | $191.5m | 840,786 | -8% | reduced |
| 20 | CITRIX SYS INC | 1.3% | $188.0m | 1,916,051 | -4% | reduced | |
| 21 | BKNG BOOKING HLDGS INC | Consumer Cyclical | 1.3% | $182.7m | 97,449 | -47% | reduced |
| 22 | ASND ASCENDIS PHARMA A S | Healthcare | 1.2% | $177.3m | 1,540,000 | 3% | added |
| 23 | META FACEBOOK INC | Communication Services | 1.2% | $174.5m | 904,284 | -51% | reduced |
| 24 | AZN ASTRAZENECA PLC | Healthcare | 1.2% | $169.2m | 4,100,000 | 6% | added |
| 25 | MSFT MICROSOFT CORP | Technology | 1.2% | $168.5m | 1,257,503 | -23% | reduced |
| 26 | ALLERGAN PLC | 1.2% | $167.4m | 1,000,000 | – | new | |
| 27 | CI CIGNA CORP NEW | Healthcare | 1.2% | $165.4m | 1,050,000 | 11% | added |
| 28 | GOOG ALPHABET INC | Communication Services | 1.1% | $153.7m | 142,223 | -51% | reduced |
| 29 | IOVA IOVANCE BIOTHERAPEUTICS INC | Healthcare | 1.0% | $140.4m | 5,725,000 | 0% | held |
| 30 | TRU TRANSUNION | Financial Services | 0.9% | $122.9m | 1,672,343 | -61% | reduced |
| 31 | SE SEA LTD | Consumer Cyclical | 0.8% | $112.1m | 3,375,000 | -51% | reduced |
| 32 | MIRATI THERAPEUTICS INC | 0.7% | $102.5m | 995,000 | -17% | reduced | |
| 33 | MYOKARDIA INC | 0.7% | $100.3m | 2,000,000 | 3% | added | |
| 34 | XLRN ACCELERON PHARMA INC | 0.7% | $97.6m | 2,375,000 | 0% | held | |
| 35 | LIBERTY GLOBAL PLC | 0.7% | $97.5m | 3,675,974 | -15% | reduced | |
| 36 | ZOGENIX INC | 0.7% | $95.6m | 2,000,000 | -2% | reduced | |
| 37 | ZAYO GROUP HLDGS INC | 0.6% | $92.8m | 2,820,000 | – | new | |
| 38 | SG7 SAGE THERAPEUTICS INC | 0.6% | $91.5m | 500,000 | -17% | reduced | |
| 39 | BABA ALIBABA GROUP HLDG LTD | Consumer Cyclical | 0.6% | $84.7m | 500,000 | 20% | added |
| 40 | AMARIN CORP PLC | 0.6% | $82.4m | 4,250,000 | 31% | added | |
| 41 | ENTA ENANTA PHARMACEUTICALS INC | Healthcare | 0.6% | $81.0m | 960,000 | 2% | added |
| 42 | ALNY ALNYLAM PHARMACEUTICALS INC | Healthcare | 0.6% | $79.8m | 1,100,000 | 120% | added |
| 43 | SPARK THERAPEUTICS INC | 0.6% | $78.8m | 770,000 | -6% | reduced | |
| 44 | GENESEE & WYO INC | 0.5% | $77.5m | 775,000 | – | new | |
| 45 | FIBROGEN INC | 0.5% | $76.8m | 1,700,000 | 86% | added | |
| 46 | SRPT SAREPTA THERAPEUTICS INC | Healthcare | 0.5% | $76.0m | 500,000 | -23% | reduced |
| 47 | NVCR NOVOCURE LTD | Healthcare | 0.5% | $75.9m | 1,200,000 | 14% | added |
| 48 | REATA PHARMACEUTICALS INC | 0.5% | $75.5m | 800,000 | 7% | added | |
| 49 | SPRINT CORPORATION | 0.5% | $70.1m | 10,675,000 | 571% | added | |
| 50 | GRFS GRIFOLS S A | Healthcare | 0.5% | $65.0m | 3,080,083 | 5% | added |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.